Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Wraps Up Axiom Acquisition

NEW YORK, Sept. 3 - Sequenom today said it has closed its acquisition of Axiom Biotechnologies.

 

Sequenom announced on Aug. 21 its plans to acquire the privately held company, which has been targeted to help Sequenom's nascent pharma division build some internal biology, assay, and drug-discovery muscle.

 

Axiom, based in Sequenom's home port of San Diego, employs 25 people and has expertise in the study of human cell lines and cell-based assay technologies. The acquisition is intended to accelerate by as much as two years Sequenom's own tender foothold in the drug-discovery arena.

 

"The acquisition of Axiom is a strategic fit for the long-term development of our pharmaceutical unit," said Toni Schuh, president and CEO of Sequenom. It "rapidly enables us to move our discoveries forward by adding internal assay and screening abilities, key technologies, a library of well characterized human cell lines, expertise and intellectual property."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.